Status:
TERMINATED
Early Indicators of Chronic Rejection in Lung Transplant
Lead Sponsor:
University of Chicago
Conditions:
Chronic Rejection in Lung Transplant
Cytokine Production in Bos Post Lung Transplant
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this research is to discover the different patterns of cytokine production in patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing rejection. This ...
Detailed Description
Lung transplant recipients are routinely followed in clinic every three months after the first year post-transplant. Spirometry with measurement of FEV1, FVC and FEF25-75 are obtained at each visit. I...
Eligibility Criteria
Inclusion
- Lung transplant recipients between the ages of 18 and 65 years old
- All patients must be able to give written informed consent
Exclusion
- Lung transplant recipients who are unable to undergo bronchoscopy
- Lung transplant recipients who are unable to give informed consent
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00449332
Start Date
March 1 2006
End Date
December 1 2013
Last Update
September 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637